Pascal Mayer

CEO at Alphanosos

FranceJoined November 2017


My background encompasses several research, management, founder and executive positions in academia, multinational pharmaceutical companies and start-ups. I co-authored 17 peer-reviewed publications and 12 patent applications, comprising princeps patents protecting Illumina's massively parallel sequencing technology. I earned my Ph.D in macromolecular biophysics from the Louis Pasteur University (now Université de Strasbourg), in Strasbourg (France).

Research areas of interest (17)

  • Physical Sciences and Exact Sciences
  • Physics
  • Separation Technologies
  • Micro- and Nanotechnology
  • Biological Sciences
  • and 12 more

Pascal Mayer didn't publish any Technology Call yet

Alphanosos is active in animal feed, medical foods, and pharma, and with the right venture partners, to become a leader in botanical plant-based natural antimicrobial control, well-being and medicine through its R&D based on proprietary Artificial Intelligence. Alphanosos’ first patent-pending disco[…]

Alphanosos’ AI guided rapid discovery technology, validated in antimicrobials and anticancer, is expected to develop within 3 weeks of experimental work with a virology partner an anti-COVID-19 treatment composed of a synergistic mix of extracts of edible plants, chosen for being available in large […]

Pascal Mayer didn't publish any Paper yet

Pascal Mayer didn't publish any Event yet

Pascal Mayer didn't publish any Job yet

Pascal Mayer didn't publish any New and Article yet

Pascal Mayer didn't publish any Education Resource yet

You are signed out

Join Innoget to connect with Pascal Mayer and thousands
of innovation-driven professionals and organizations